Integrated Clinical-Behavioral Interventions to Accomplish Weight Loss

描述（由申请人提供）： 来自疗效试验的大量证据，包括霍普金斯研究人员进行的几项行为干预试验，都证明减肥是可以实现的。然而，初级保健提供者通常没有直接参与干预。我们提出了一个3组，随机试验，以确定两个综合临床行为干预（ICBI）的有效性。参与者将是300名超重或肥胖的高血压患者，他们是两个初级保健诊所的患者。对照组以及两种ICBI将接受循证计划，以改善高血压控制。一个ICBI，称为ICBI-IP，是一个多渠道的干预与亲自访问提供的健康顾问在霍普金斯中心。这种干预措施类似于疗效试验中测试的传统面对面干预措施;然而，为了降低成本和提高效率，一些面对面的联系方式被其他类型的联系方式（电话、网络、电子邮件）取代。另一个ICBI，称为ICBI-Remote，是一种多渠道干预（电话，网络，电子邮件），由领先的疾病管理公司Healthways，Inc.的训练有素的顾问实施，无需亲自访问。这项研究工作建立在研究人员以前进行的研究基础上。两种ICBI都是理论指导的干预措施，改编自PREMIER，PREMIER是一项有效性试验，其中干预措施降低了体重并控制了高血压。每个ICBI将实施完善的行为技术来实现减肥，每个ICBI将使用基于网络的工具来促进顾问，参与者和临床医生之间的沟通;参与者的自我监测;以及顾问和临床医生的反馈。两个ICBI将积极与初级保健提供者接触。主要结局变量为BMI，次要结局变量为高血压控制。两种ICBI都应该减肥。关键问题是每个项目的减肥程度。ICBI-IP可能比ICBI-Remote更大程度地减轻体重。尽管如此，ICBI-Remote应该更便宜，更灵活。ICBI-IP可以在各种环境中实施（例如健康计划，大型诊所），而ICBI-Remote具有易于“可扩展”的优势，即如果成功，它可以快速实施。总之，这项翻译研究应该为控制体重和改善超重或肥胖医疗患者的高血压控制提供科学依据。

DESCRIPTION (provided by applicant): An extensive body of evidence from efficacy trials, including several behavioral intervention trials conducted by the Hopkins investigators, has documented that weight loss is achievable. However, primary care providers typically had no direct involvement in the interventions. We propose a 3 group, randomized trial to determine the effectiveness of two integrated clinical-behavioral interventions (ICBIs). Participants will be 300 overweight or obese individuals with medication-treated hypertension, who are patients at two primary care clinics. The comparison group, as well as both ICBIs, will receive an evidence-based program to improve hypertension control. One ICBI, termed ICBI-IP, is a multi-channel intervention with in-person visits delivered by health counselors at the Hopkins center. This intervention is similar to traditional in-person interventions tested in efficacy trials; however, some in-person contacts are replaced with other types of contacts (telephone, web, email) in order to reduce costs and improve efficiency. The other ICBI, termed ICBI-Remote, is a multi-channel intervention (telephone, web, email) without in-person visits implemented by trained counselors of Healthways, Inc, a leading Disease Management company. This research effort builds upon previous research conducted by the investigators. Both ICBIs will be theory-guided interventions, adapted from PREMIER, an efficacy trial in which interventions lowered weight and controlled hypertension. Each ICBI will implement well-established behavioral techniques to accomplish weight loss, and each will use a web-based tool to facilitate communication among counselors, participants and clinicians; self- monitoring by participants; and feedback by counselors and clinicians. Both ICBIs will actively engage primary care providers. The primary outcome variable will be BMI and the secondary outcome hypertension control. Both ICBI should reduce weight. Critical questions are the extent of weight loss from each program. ICBI-IP might reduce weight to a greater extent than ICBI-Remote. Still, ICBI-Remote should be less expensive and more flexible. ICBI-IP could be implemented in a variety of settings (e.g. wellness programs, large clinics), while ICBI-Remote has the advantage of being readily 'scalable', that is, if successful, it could be rapidly implemented. In short, this translation study should provide the scientific foundation for efforts to control weight and improve hypertension control in overweight or obese medical patients.